These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 20859548

  • 1. Management of acute attacks of hereditary angioedema: potential role of icatibant.
    Longhurst HJ.
    Vasc Health Risk Manag; 2010 Sep 07; 6():795-802. PubMed ID: 20859548
    [Abstract] [Full Text] [Related]

  • 2. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
    Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT.
    N Engl J Med; 2010 Aug 05; 363(6):532-41. PubMed ID: 20818888
    [Abstract] [Full Text] [Related]

  • 3. Icatibant for the treatment of hereditary angioedema.
    Cole SW, Lundquist LM.
    Ann Pharmacother; 2013 Jan 05; 47(1):49-55. PubMed ID: 23249729
    [Abstract] [Full Text] [Related]

  • 4. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
    Prescrire Int; 2010 Nov 05; 19(110):245-7. PubMed ID: 21284353
    [Abstract] [Full Text] [Related]

  • 5. Icatibant for hereditary angioedema.
    Gras J.
    Drugs Today (Barc); 2009 Dec 05; 45(12):855-64. PubMed ID: 20135020
    [Abstract] [Full Text] [Related]

  • 6. Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
    Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D, Riedl M, Li H, Craig T, Bloom BJ, Reshef A.
    Ann Allergy Asthma Immunol; 2011 Dec 05; 107(6):529-37. PubMed ID: 22123383
    [Abstract] [Full Text] [Related]

  • 7. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
    Baş M, Greve J, Hoffmann TK, Reshef A, Aberer W, Maurer M, Kivity S, Farkas H, Floccard B, Arcoleo F, Martin L, Sitkauskiene B, Bouillet L, Schmid-Grendelmeier P, Li H, Zanichelli A.
    Allergy; 2013 Nov 05; 68(11):1452-9. PubMed ID: 24111645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [EFFICACY, PHARMACOKINETICS, AND SAFETY OF ICATIBANT FOR THE TREATMENT OF JAPANESE PATIENTS WITH AN ACUTE ATTACK OF HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].
    Hide M, Fukunaga A, Maehara J, Eto K, Hao J, Vardi M, Nomoto Y.
    Arerugi; 2018 Nov 05; 67(2):139-147. PubMed ID: 29553114
    [Abstract] [Full Text] [Related]

  • 10. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P, Holko P, Paszulewicz A, Obtułowicz K.
    Pneumonol Alergol Pol; 2013 Nov 05; 81(2):95-104. PubMed ID: 23420425
    [Abstract] [Full Text] [Related]

  • 11. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility.
    Otani IM, Lumry WR, Hurwitz S, Li HH, Craig TJ, Holtzman NS, Iandoli MI, Tucker J, Riedl MA, Zuraw BL, Banerji A.
    J Allergy Clin Immunol Pract; 2017 Nov 05; 5(2):442-447.e1. PubMed ID: 27818136
    [Abstract] [Full Text] [Related]

  • 12. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
    Farkas H, Reshef A, Aberer W, Caballero T, McCarthy L, Hao J, Nothaft W, Schranz J, Bernstein JA, Li HH.
    J Allergy Clin Immunol Pract; 2017 Nov 05; 5(6):1671-1678.e2. PubMed ID: 28601641
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Icatibant as acute treatment for hereditary angioedema in adults.
    Farkas H.
    Expert Rev Clin Pharmacol; 2016 Jun 05; 9(6):779-88. PubMed ID: 27123689
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of acute hereditary angioedema attacks with self-administered icatibant in patients with venous access problems.
    Wiednig M.
    BMJ Case Rep; 2013 Apr 25; 2013():. PubMed ID: 23625675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Icatibant: HOE 140, JE 049, JE049.
    Drugs R D; 2004 Apr 25; 5(6):343-8. PubMed ID: 15563238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.